Glaukos Current Ratio 2014-2022 | GKOS

Glaukos current ratio from 2014 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Glaukos Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2022-06-30 $0.47B $0.07B 6.78
2022-03-31 $0.49B $0.06B 8.84
2021-12-31 $0.49B $0.06B 7.67
2021-09-30 $0.50B $0.06B 7.91
2021-06-30 $0.49B $0.35B 1.40
2021-03-31 $0.47B $0.34B 1.41
2020-12-31 $0.47B $0.05B 9.45
2020-09-30 $0.45B $0.05B 9.73
2020-06-30 $0.45B $0.06B 8.27
2020-03-31 $0.23B $0.05B 4.53
2019-12-31 $0.26B $0.06B 4.56
2019-09-30 $0.21B $0.03B 6.32
2019-06-30 $0.20B $0.03B 6.49
2019-03-31 $0.18B $0.03B 6.72
2018-12-31 $0.18B $0.03B 5.82
2018-09-30 $0.18B $0.03B 7.08
2018-06-30 $0.16B $0.02B 7.63
2018-03-31 $0.15B $0.02B 7.90
2017-12-31 $0.15B $0.03B 5.58
2017-09-30 $0.14B $0.02B 6.93
2017-06-30 $0.13B $0.02B 6.86
2017-03-31 $0.12B $0.02B 8.45
2016-12-31 $0.12B $0.02B 7.09
2016-09-30 $0.12B $0.02B 6.08
2016-06-30 $0.11B $0.02B 6.01
2016-03-31 $0.11B $0.02B 5.82
2015-12-31 $0.10B $0.02B 5.11
2015-09-30 $0.11B $0.02B 5.33
2015-06-30 $0.11B $0.02B 5.33
2015-03-31 $0.01B $0.02B 0.73
2014-12-31 $0.01B $0.02B 0.52
2014-09-30 $0.00B 0.00
2014-06-30 $0.00B 0.00
2014-03-31 $0.00B 0.00
2013-12-31 $0.01B $0.01B 2.19
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.520B $0.294B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $198.711B 20.24
Edwards Lifesciences (EW) United States $51.226B 36.24
Alcon (ALC) Switzerland $28.513B 24.14
STERIS (STE) Ireland $16.630B 20.66
Teleflex (TFX) United States $9.450B 15.06
Fresenius Medical Care AG KGaA (FMS) Germany $8.228B 7.59
Penumbra (PEN) United States $7.184B 861.82
Globus Medical (GMED) United States $5.928B 30.24
Integer Holdings (ITGR) United States $2.061B 16.12
Nevro (NVRO) United States $1.649B 0.00
Paragon 28 (FNA) United States $1.368B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.031B 15.78
Artivion (AORT) United States $0.558B 53.23